article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

The CRO “successfully adapted the business to work in the midst of a global pandemic, and supported the development of therapies to combat the COVID-19 pandemic itself,” said Pamplona’s managing partner John Halsted.

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute, and progress drug discovery programs towards the clinic.

Reagent 52